wow888 secret bonus no deposit

Dallas (7-8) at Philadelphia (12-3) Sunday, 1 p.m. EST, Fox BetMGM NFL Odds: Eagles by 7 1/2 Against the spread: Dallas 6-9; Philadelphia 9-6 Series record: Cowboys lead 74-58. Last meeting: Jalen Hurts threw two touchdowns and ran for two more in the Eagles’ 34-6 rout of the Cowboys at Dallas on Nov. 10. Last week: Cowboys defeated the Buccaneers 26-24; Eagles lost 36-33 at Washington. Cowboys offense: overall (16), rush (28), pass (10), scoring (20) Cowboys defense: overall (27), rush (27), pass (21), scoring (30) Eagles offense: overall (6), rush (1), pass (31), scoring (8) Eagles defense: overall (1), rush (9), pass (2), scoring (5) Turnover differential: Cowboys minus-3; Eagles plus-6 RB Saquon Barkley is 162 yards shy of becoming the ninth player in NFL history to rush for 2,000 yards in a season and needs 268 yards to break Eric Dickerson’s single-season rushing record of 2,105 yards, set in 1984. In his past five games, QB Cooper Rush has passed for nine touchdowns and one interception, looking more comfortable of late after taking over for Dak Prescott in November. Rush is 9-2 as a starter against teams that are not the Eagles. Dallas’s rushing defense vs. Barkley. Can anyone stop him? The Cowboys will be the latest to try to corral Barkley, who has 1,838 rushing yards and 2,114 scrimmage yards, both of which lead the NFL. Dallas ranks 28th in the NFL in rushing defense, allowing an average of 135.9 yards a game. Philadelphia, behind Barkley’s stellar play, tops the league at 187.9 yards a game on the ground. Cowboys: WR CeeDee Lamb will miss the final two games after getting shut down over the sprained right shoulder he's been dealing with the second half of the season. ... LB Eric Kendricks (calf) warmed up but wasn’t able to play against Tampa Bay last week. Eagles: Hurts was ruled out. He remained in the concussion protocol after leaving the game following a 13-yard scramble with 9:52 left in the first quarter last week. Kenny Pickett is starting in his place. ... DE Josh Sweat (ankle) and Jordan Davis also left the game at Washington early. ... QB Ian Book was signed to the practice squad Thursday. The Cowboys made the playoffs in each of the previous three seasons, but were eliminated prior to their game against Tampa Bay last week when the Commanders came back from a 13-point, fourth-quarter deficit to beat Philadelphia. ... Dallas is 5-2 on the road. ... The Eagles can clinch the NFC East and one of the conference's top two seeds with a victory. ... On Jan. 11, 1981, the Eagles defeated the Cowboys 20-7 at their former home, Veterans Stadium. Wilbert Montgomery rushed for a 42-yard touchdown to give Philadelphia an early lead that propelled the Eagles to their first Super Bowl appearance. LB Micah Parsons needs half a sack to reach double digits in sacks for the fourth straight season to begin his career and would become just the fifth player to accomplish the feat in NFL history. ... K Brandon Aubrey made a 53-yard and two 58-yard field goals against the Buccaneers, upping his league-leading total to 14 made of 50-plus yards. ... Pickett went 14 of 24 for 143 yards and a TD in relief of Hurts last week. Pickett, a 2022 first-round pick, is no stranger to starting, going 14-10 as Pittsburgh’s QB earlier in his career. ... Defensive back C.J. Gardner-Johnson was ejected against Washington for committing two unsportsmanlike penalties. ... The Eagles already set a team record for rushing yards in a season with 2,818, and they are within four rushing touchdowns of tying the club’s best single-season mark of 32, set in 2022. ... Barkley needs just 33 yards from scrimmage to break McCoy’s mark of 2,146 scrimmage yards, set in 2013. ... WR A.J. Brown leads the NFL with 16.3 yards a catch and ranks ninth in the league with 1,043 receiving yards, joining Mike Quick (1983–85) as the only Philadelphia players to have three consecutive 1,000-yard receiving seasons. Philadelphia’s defense is tied for ninth in the NFL with a plus-6 turnover margin. With Hurts sidelined, Philadelphia giving up an uncharacteristic 36 points last week and the chance to clinch the division, the Eagles defense likely will be extra motivated to have a good performance against a Dallas offense that ranks 21st in the league in points. AP NFL: https://apnews.com/hub/NFLPIAA Class 3A football: Northwestern Lehigh’s defense is better with Jackson Huber in middle of itADIB-Egypt announces 1 billion EGP digital transformation planwow888 secret bonus no deposit 。

ORCHARD PARK, N.Y. (AP) — In a season that began with many questions and lowered expectations , it was apt watching Bills quarterback Josh Allen join coach Sean McDermott lay on the cold, wet sideline to make snow angels in celebrating Buffalo’s earliest clinching of a division title in team history. That Allen took part was no surprise. The newly engaged 28-year-old has maintained the happy-go-lucky approach he brought with him to Buffalo as a raw-talented athlete in 2018, while gradually blossoming into one of the NFL’s elite quarterbacks. For McDermott, it was a pleasant surprise to see the usually reserved eight-year coach finally let his hair down — figuratively, because the few jokes he does make are usually about being bald. With his latest do-it-all three-TD outing — one rushing, one receiving and, the coup de grace, being credited with receiving his own pass for a score off a lateral from Amari Cooper — in a 35-10 win over San Francisco on Sunday night , Allen continued making his strongest NFL MVP case. What’s also becoming apparent is how much McDermott deserves consideration for coach of the year honors. Without the two, the Bills (10-2) wouldn’t be in this position in becoming just the eighth NFL team — and first since Indianapolis in 2009 — to clinch a division title with at least five games remaining in their schedule. It’s reflective of how the two have grown together in what, on the outside, could be perceived as an odd couple relationship between an offensive-minded, swashbuckling quarterback and a defensive-minded coach, too often knocked for being too conservative. Perhaps, it’s Allen’s boyish nature that has brought out the risk-taker in McDermott, who has carried over the aggressive approach he takes to defense by placing trust in his quarterback. It’s become apparent in everything the Bills have accomplished so far in having at least 10 wins through 12 games for just the fifth time in team history, and first since 1991, when Buffalo was led by eventual Hall of Famers in coach Marv Levy and quarterback Jim Kelly. Buffalo has won seven straight since consecutive losses to Baltimore and Houston. And the Bills have scored 30 or more points in six straight outings, matching the team record set in 2004. Allen is doing more with less on an offense that was supposed to be hampered following the offseason departures of receivers Stefon Diggs and Gabe Davis and center Mitch Morse. The Bills are more balanced in leaning on their running attack, while Allen has also curtailed his turnover-prone ways. He's lost two fumbles and thrown just five interceptions after being picked off a career-worst 18 times last season. Meantime, McDermott has taken a different approach to fourth down situations. The Bills have converted 13 of 15 fourth down attempts after going 9 of 16 last season and 7 of 13 in 2022. The most fourth down attempts during McDermott’s tenure came in 2021, when Buffalo converted just 11 of 22. This is but an example of the bond the quarterback and coach have built in a shared objective of overcoming past playoff failures. Clinching a division title is but one step, with the Bills now focused on catching the Kansas City Chiefs (11-1), whom they’ve beaten already , for the AFC’s top seed. In calling it the team’s next goal, McDermott went off script from his usual game-at-a-time message by noting the importance of celebrating a division-clinching win, if only for one day. “Being 50 years old and 20-plus years in this league, I’ve learned to try and enjoy the moments,” McDermott said. “And this is a moment, right?” It certainly was. What’s working Turnover differential. Buffalo’s defense forced three fumbles, including one at its goal line, while the offense didn’t commit a giveaway. The Bills upped their league-leading turnover differential entering Monday to plus-17. What needs help Run defense. Though the conditions were snowy and slick, the Bills allowed 119 yards rushing in the first half before the 49ers were forced to start passing the ball once the score became lopsided. Buffalo particularly struggled in stopping Christian McCaffrey, who had 53 yards on seven carries before leaving the game with a potential season-ending knee injury . Stock up LB Matt Milano was in on five tackles while playing 37 of 48 defensive snaps in his first outing in nearly 14 months after being sidelined by a broken right leg and torn left biceps. Stock down CB Kaiir Elam, the 2022 first-round pick was a healthy inactive for a second straight outing, and still having difficulty finding a regular role. Injuries None reported. Key number 9-0 — The Bills' home record going back to last season, marking their second-longest run in team history. Next steps Hit the road for two outings, starting with a trip to face the Los Angeles Rams on Sunday. AP NFL: https://apnews.com/hub/nfl

None

Enron , once among the largest energy companies in the U.S., has become a punchline since it famously collapsed amid inflated profits and corporate fraud in 2001. Now, social media posts, a slick promotional video and a revamped website suggest the infamous company is making a comeback. On Dec. 2, it posted promotional videos on TikTok , BlueSky and X about adapting to the changing world featuring inspiring imagery and diverse voices claiming "I am Enron" with the tagline, “We're back. Can we talk?” To coincide with the video and website launch, cryptocurrency bloggers speculated Enron will be involved in cryptocurrency exchange. Others speculated the rebranding is fake or parody . THE SOURCES Enron.com terms of use page Will Chabot , managing director of media strategy for Stu Loeser & Co. Enron Corporation articles of incorporation United States Patent and Trademark Office Wayback Machine archives of Enron.com WHAT WE FOUND On Dec. 2, a company calling itself Enron Corporation published a promotional video on social media, introduced a new website and issued a press release announcing a relaunch of the company. But the relaunched website calls itself a parody. The new company with the infamous name is owned by Connor Gaydos, the co-founder of satirical conspiracy group “Birds Aren’t Real.” A disclaimer on the website’s terms of service page reads, “THE INFORMATION ON THE WEBSITE IS FIRST AMENDMENT PROTECTED PARODY, REPRESENTS PERFORMANCE ART, AND IS FOR ENTERTAINMENT PURPOSES ONLY.” VERIFY reached out to the media contact listed on Enron’s website and in the press release about the site’s relaunch. Will Chabot , spokesperson for the current Enron brand and managing director of media strategy for Stu Loeser & Co., would not confirm or deny if the company was real or parody, but did direct VERIFY to the company’s articles of incorporation and press release about the relaunch. “I understand you had some questions about Enron's launch. While I'm not able to answer all of them (we'll have more to share soon - including a big announcement in the energy space - and will be sure to keep you in the loop),” Chabot told VERIFY. The latest iteration of Enron Corporation’s articles of incorporation were filed in Delaware on Feb. 28, 2024 by Gaydos, according to records provided to VERIFY by Chabot. Gaydos is the co-founder of Birds Aren’t Real , a satirical conspiracy group founded in 2017 that jokingly claims the U.S. government has been replacing living birds with surveillance drones. Gaydos registered the Enron trademark on May 13, 2020, through his The College Company LLC, which also has registered trademarks for Birds Aren’t Real. According to the trademark application for Enron, the trademark is used for shirts and other merchandise. The new website has merchandise for sale. Archival versions of Enron.com dating back to 1998 are available on The Wayback Machine. In January of 2024, the website domain of enron.com was available for purchase , archives of the page show. The last time that URL represented the bankrupt energy giant was in 2007 . There is no evidence to support claims the Enron brand was relaunched as a cryptocurrency firm, as some have speculated. There is a page on Enron’s new website titled “decentralization,” which is a common term to describe the kind of technology behind cryptocurrency. The website says, “Decentralized technology is advancing, and we will of course have a role to play in its future. We couldn't be more excited to show you, but until then please stay vigilant and avoid falling for scams. When we announce something, you'll know.”

Pfizer hosted a discussion with sell-side analysts to provide an update on one of the vaccine pipeline items – a second-generation Clostridioides difficile (C. diff) vaccine effort in Phase 2. Goldman Sachs analyst Chris Shibutani maintained a Buy rating on Pfizer, Inc PFE with a price target of $33 . Shibutani recalled that Pfizer had reported negative results from a Phase 3 study for a first-generation asset in March 2022, where the primary endpoint was unmet. Also Read: Elon Musk’s xAI To Expand With New Chatbot App Still, results did include signals from secondary endpoints that suggested reduced disease severity. Pfizer has since been exploring updated formulations (reducing the 3-dose regimen to 2 doses), including a version in Phase 2. Immunogenicity data are anticipated in 2025, with potential for advancement into Phase 3 by the end of 2025. For a potential Phase 3 study, Shibutani noted the objective would be to discern the potential to reduce the severity of a C. diff infection (CDI) instead of aiming to reduce the risk and prevention of disease. Pfizer estimates ~500k infections annually in the U.S., and no vaccine options currently available. Acknowledging that there is an unmet need The analyst acknowledged that there is an unmet need and said the data thus far suggests a potential basis for a path forward for the program in the context of comments from R&D leadership during the discussion Shibutani hosted with investors. The emphasis on the forward will be on programs with the most significant potential for economic returns. The analyst expects that investor enthusiasm will likely remain relatively subdued, especially in the context of uncertainties deriving from health policy dynamics relating to vaccines, that are an overhang to sentiment. Shibutani does not currently include revenue estimates for a C. diff vaccine in his model and looks to monitor data updates and decisions regarding plans for this program to guide his forecasts in the future. Separately, the analyst flagged Pfizer management’s mention of the fourth generation 25-valent pneumococcal vaccine (PCV), which management affirms continues to progress in Phase 2. Shibutani recalled that Pfizer had previously commented that the immunogenicity data from Phase 1 were encouraging, as highlighted by the improved immunogenicity observed for serotype 3. Pfizer is currently in a Phase 2 proof-of-concept study for its second-generation Clostridioides difficile (C. diff) vaccine, PF-07831694. This vaccine targets C. diff toxins A and B, which cause Clostridioides difficile infection (CDI). Their goal for the second generation is to build off the 1st generation’s efficacy and duration by developing a more potent, more durable formulation, allowing for a 2-dose regiment (instead of 3-dose), resulting in higher and faster series completion. After evaluating adjuvants in formulation for their next-generation candidates, Pfizer noted they can increase the strength or magnitude of the immune response, potentially resulting in lower doses. Pfizer advanced 1 of the three updated 2nd-generation candidates to Phase 2 based on Phase 1/2 safety and immunogenicity data. The Phase 2 trial endpoints will evaluate the immunogenicity and safety of the 2-dose regimen. Trial data is expected in 2025, with a potential Phase 3 start in late 2025, pending positive results. Pfizer in Phase 2 is the furthest along of the C. diff vaccine assets. Idorsia Pharmaceuticals initiated Phase 1 for their competing C. diff asset in July. Vaxxilon and Matrivax Research & Development Corporation both have preclinical assets. GSK Plc’s GSK CDI vaccine completed a Phase 1 trial in 2022 but is no longer listed as a pipeline asset. Pfizer stock has dropped over 11.5% year-to-date. Investors can gain exposure to the stock through SPDR S&P 500 SPY and Vanguard S&P 500 ETF VOO . Price Action: PFE stock is up 0.82% at $26.58 at the last check on Monday. Also Read: Biden Administration Targets Chinese Firm Over Taiwan Semiconductor Chip Found in Huawei Tech Photo via Shutterstock © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.NC State defensive coordinator Tony Gibson is named head coach at Marshall

In the Israeli-occupied Golan Heights, residents celebrate fall of AssadMissoulian week in review: Local news recap for Dec. 21-27Greg Norman’s tenure as LIV Golf chief executive is coming to an end, with the Australian legend confirming he’s “fine” with being replaced at the top of the controversial breakaway tour. The former world No.1 has been in charge since 2021 and has been front and centre of the tension between the PGA and LIV tours. TGL Golf League | Watch LIVE & exclusive on FOX SPORTS, available on Kayo. New to Kayo? Get your first month for just $1 . Limited time offer. “I’ve seen (LIV) come from a business model on paper to giving birth on the golf course to where it is today,” he told Indiana news TV station WISH-TV. “Is there going to be a new CEO? Yes. There will be a new CEO. I’m fine with that. “Will I always have a place and be involved with LIV to some capacity? Yes. “I’ll always have that. Because the impact that has been created in the game of golf by LIV, I’ve had a small, small piece of that, which I’m proud of.” Former NBA and NHL executive Scott O’Neil is expected to replace Norman at the top, with a deal between the respective tours still being worked on after a framework agreement was signed in June 2023. Norman has served as golf’s disrupter by signing top players on huge deals to the Saudi-backed league and is proud of what he’s achieved. “Everywhere you look – in the first couple years, everybody was lambasting us,” he said. “And now all of a sudden, everybody’s trying to follow us. And I think everybody should take a step back and say, ‘Oh my gosh. How good has this been for the game of golf?’” Negotiations for the deal are ongoing, with PGA tour policy board member Tigers Woods fed up by the slow process. “I think all of us who have been a part of this process would have thought it would have happened quicker than this,” he said. “But we wish we would have had something more concrete and further along than we are right now. I think something will get done. In what form or shape, I don’t know yet.”